FDA to Import Syphilis Drug From France Amid Shortage
THURSDAY, Jan. 11, 2024 (HealthDay News) — Amid an ongoing shortage of the first-line treatment for syphilis in the United States, the U.S. Food and Drug Administration will allow the importation of a different syphilis drug from a French drugmaker. In a letter from Laboratoires Delbert, the Paris-based company said it’sContinue Reading